Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Cari Gallman | EVP Corporate Affairs | 2024-08-01 | 384 | $48.17 | $18.50kSell |
Karin Shanahan | EVP Glob. Prod. Dev. Supply | 2024-04-01 | 1,196 | $52.99 | $63.38kSell |
David V. Elkins | EVP Chief Financial Officer | 2024-03-10 | 2,353 | $53.79 | $126.57kSell |
Samit Hirawat | EVPChief Med.Offr.Drug Dev. | 2024-03-10 | 2,068 | $53.79 | $111.24kSell |
Samit Hirawat | EVPChief Med.Offr.Drug Dev. | 2024-03-10 | 1,807 | $53.79 | $97.20kSell |
Robert M. Plenge | EVP Chief Research Officer | 2024-03-10 | 1,436 | $53.79 | $77.24kSell |
Robert M. Plenge | EVP Chief Research Officer | 2024-03-10 | 283 | $53.79 | $15.22kSell |
Robert M. Plenge | EVP Chief Research Officer | 2024-03-10 | 246 | $53.79 | $13.23kSell |
David V. Elkins | EVP Chief Financial Officer | 2024-03-10 | 2,824 | $53.79 | $151.90kSell |
Sandra Leung | EVP General Counsel | 2024-03-10 | 11,695 | $53.79 | $629.07kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Vanguard Group Inc | 9.20% | 186,571,157 | $9.29B | Institution |
Blackrock Inc | 7.83% | 158,658,853 | $7.90B | Institution |
State Street Corp | 4.51% | 91,445,366 | $4.55B | Institution |
Jpmorgan Chase Co | 3.68% | 74,629,926 | $3.72B | Institution |
Charles Schwab Investment Management Inc | 2.91% | 59,061,674 | $2.94B | Institution |
Capital International Investors | 2.73% | 55,406,592 | $2.76B | Institution |
Geode Capital Management LLC | 2.08% | 42,167,521 | $2.10B | Institution |
Fmr LLC | 2.01% | 40,664,822 | $2.03B | Institution |
Norges Bank | 1.61% | 32,594,416 | $1.62B | Institution |
Morgan Stanley | 1.29% | 26,155,105 | $1.30B | Institution |